RCKT icon

Rocket Pharmaceuticals

58 hedge funds and large institutions have $141M invested in Rocket Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 10 closing their positions.

Holders
58
Holders Change
-2
Holders Change %
-3.33%
% of All Funds
1.55%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
8
Increased
26
Reduced
14
Closed
10
Calls
$7K
Puts
$1K
Net Calls
+$6K
Net Calls Change
-$31K
Name Market Value Shares Shares
Change
Shares
Change %
TRCT
51
Tower Research Capital (TRC)
New York
$10K 1,333 -1,568 -54%
LTFS
52
Ladenburg Thalmann Financial Services
Florida
$7K 925 +125 +16%
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$6K 853 +853 New
CSS
54
Cubist Systematic Strategies
Connecticut
$5K 700
CG
55
Cutler Group
California
$5K 700 +500 +250%
MCM
56
Manchester Capital Management
Vermont
$3K 400
Barclays
57
Barclays
United Kingdom
$1K 136 -353 -72%
Geode Capital Management
58
Geode Capital Management
Massachusetts
$607 82,072 -54 -0.1%
RIM
59
RS Investment Management
California
-1,585,006 Closed
PCA
60
Private Capital Advisors
Connecticut
-341,000 Closed
EI
61
EAM Investors
California
-128,911 Closed
NC
62
Nexthera Capital
New York
-42,000 Closed
Acadian Asset Management
63
Acadian Asset Management
Massachusetts
-40,827 Closed
Federated Hermes
64
Federated Hermes
Pennsylvania
-30,000 Closed
MG
65
Meditor Group
Bermuda
-12,594 Closed
OAM
66
Oxford Asset Management
United Kingdom
-10,075 Closed
PAM
67
Panagora Asset Management
Massachusetts
-9,378 Closed
Bank of America
68
Bank of America
North Carolina
-4,403 Closed
Group One Trading
69
Group One Trading
Illinois
Simplex Trading
70
Simplex Trading
Illinois